Clinical Trial Update: Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing rectal bacteriotherapy, fecal microbiota transplantation, or oral vancomycin for recurrent Clostridium difficile infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)
• oral vancomycin (vancomycin)
• rectal bacteriotherapy

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Clostridium Difficile | Phase 3 | Status: UNKNOWN